These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 11133088
1. 1H-pyrazole-1-carboxamidines: new inhibitors of nitric oxide synthase. Lee Y, Martásek P, Roman LJ, Silverman RB. Bioorg Med Chem Lett; 2000 Dec 18; 10(24):2771-4. PubMed ID: 11133088 [Abstract] [Full Text] [Related]
2. Inhibition of nitric oxide synthase with pyrazole-1-carboxamidine and related compounds. Southan GJ, Gauld D, Lubeskie A, Zingarelli B, Cuzzocrea S, Salzman AL, Szabó C, Wolff DJ. Biochem Pharmacol; 1997 Aug 01; 54(3):409-17. PubMed ID: 9278100 [Abstract] [Full Text] [Related]
3. N-Phenylamidines as selective inhibitors of human neuronal nitric oxide synthase: structure-activity studies and demonstration of in vivo activity. Collins JL, Shearer BG, Oplinger JA, Lee S, Garvey EP, Salter M, Duffy C, Burnette TC, Furfine ES. J Med Chem; 1998 Jul 16; 41(15):2858-71. PubMed ID: 9667974 [Abstract] [Full Text] [Related]
4. Pyrazoles and pyrazolines as neural and inducible nitric oxide synthase (nNOS and iNOS) potential inhibitors (III). Carrión MD, López Cara LC, Camacho ME, Tapias V, Escames G, Acuña-Castroviejo D, Espinosa A, Gallo MA, Entrena A. Eur J Med Chem; 2008 Nov 16; 43(11):2579-91. PubMed ID: 18325637 [Abstract] [Full Text] [Related]
5. Aromatic reduced amide bond peptidomimetics as selective inhibitors of neuronal nitric oxide synthase. Hah JM, Martásek P, Roman LJ, Silverman RB. J Med Chem; 2003 Apr 24; 46(9):1661-9. PubMed ID: 12699384 [Abstract] [Full Text] [Related]
6. Heteroalicyclic carboxamidines as inhibitors of inducible nitric oxide synthase; the identification of (2R)-2-pyrrolidinecarboxamidine as a potent and selective haem-co-ordinating inhibitor. Young RJ, Alderton W, Angell AD, Beswick PJ, Brown D, Chambers CL, Crowe MC, Dawson J, Hamlett CC, Hodgson ST, Kleanthous S, Knowles RG, Russell LJ, Stocker R, Woolven JM. Bioorg Med Chem Lett; 2011 May 15; 21(10):3037-40. PubMed ID: 21482467 [Abstract] [Full Text] [Related]
12. Evaluation of new L-thiocitrulline derivatives as inhibitors of nitric oxide synthase. Ware RW, King SB. Bioorg Med Chem Lett; 2000 Dec 18; 10(24):2779-81. PubMed ID: 11133090 [Abstract] [Full Text] [Related]
15. Synthesis and evaluation of new sulfur-containing L-arginine-derived inhibitors of nitric oxide synthase. Ichimori K, Stuehr DJ, Atkinson RN, King SB. J Med Chem; 1999 May 20; 42(10):1842-8. PubMed ID: 10346937 [Abstract] [Full Text] [Related]
16. Inhibition of nitric oxide synthase isoforms by porphyrins. Wolff DJ, Naddelman RA, Lubeskie A, Saks DA. Arch Biochem Biophys; 1996 Sep 01; 333(1):27-34. PubMed ID: 8806750 [Abstract] [Full Text] [Related]
17. Evaluating the role of inducible nitric oxide synthase using a novel and selective inducible nitric oxide synthase inhibitor in septic lung injury produced by cecal ligation and puncture. Okamoto I, Abe M, Shibata K, Shimizu N, Sakata N, Katsuragi T, Tanaka K. Am J Respir Crit Care Med; 2000 Aug 01; 162(2 Pt 1):716-22. PubMed ID: 10934111 [Abstract] [Full Text] [Related]
18. Inhibition of nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM) in vitro: antinociceptive and cardiovascular effects. Handy RL, Harb HL, Wallace P, Gaffen Z, Whitehead KJ, Moore PK. Br J Pharmacol; 1996 Sep 01; 119(2):423-31. PubMed ID: 8886430 [Abstract] [Full Text] [Related]